Different Responses to Drug Safety Screening Targets between Human Neonatal and Infantile Heart Tissue and Cardiac Bodies Derived from Human-Induced Pluripotent Stem Cells
Aims. Induced pluripotent stem cell-derived cardiomyocytes (iPS-CMs) have become a promising tool in cardiovascular safety pharmacology. Immaturity of iPS-CMs remains an ongoing concern. We compared electrophysiological and contractile features of cardiac bodies (hiPS-CBs) derived from human-induced...
Saved in:
Main Authors: | Jan Trieschmann, Moritz Haustein, Annette Köster, Jürgen Hescheler, Konrad Brockmeier, Gerardus Bennink, Tobias Hannes |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-01-01
|
Series: | Stem Cells International |
Online Access: | http://dx.doi.org/10.1155/2019/6096294 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Electrical Stimulation Promotes Cardiac Differentiation of Human Induced Pluripotent Stem Cells
by: Damián Hernández, et al.
Published: (2016-01-01) -
Mitochondrial Fusion by M1 Promotes Embryoid Body Cardiac Differentiation of Human Pluripotent Stem Cells
by: Jarmon G. Lees, et al.
Published: (2019-01-01) -
Evaluation of the cardiotoxicity of Echinochrome A using human induced pluripotent stem cell-derived cardiac organoids
by: Su-Jin Lee, et al.
Published: (2025-01-01) -
Human Neonatal Thymus Mesenchymal Stem Cells Promote Neovascularization and Cardiac Regeneration
by: Shuyun Wang, et al.
Published: (2018-01-01) -
Protocol for differentiating cardiomyocytes and generating engineered heart tissues from human feeder-free extended pluripotent stem cells
by: Zhongjun Wan, et al.
Published: (2025-03-01)